- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Integrating Support Services and Caregiver Roles in mCRC Care
Medical experts explore the psychological and emotional aspects of decision-making for patients in the third-line stage of metastatic colorectal cancer, recommend involving support services like social work or palliative care, and discuss the caregiver’s role in supporting patients through these psychosocial challenges.
EP: 1.Navigating Beyond FOLFOX/FOLFIRI: Key Therapies in Advanced mCRC
EP: 2.Real-World Impact of SUNLIGHT Outcomes in mCRC
EP: 3.Fruquintinib in mCRC: Key Insights From FRESCO-2
EP: 4.Comparing mCRC Therapies: FTD/TPI Plus Bevacizumab, Fruquintinib, and Regorafenib
EP: 5.Optimizing mCRC Therapy Sequencing: Key Considerations and Future Directions
EP: 6.Guiding Patients Through Third-Line mCRC Therapy Decisions
EP: 7.Navigating Toxicity: Comparing Third-Line mCRC Therapies
EP: 8.Evaluating Quality of Life and Adherence With mCRC Treatment Options
EP: 9.Integrating Support Services and Caregiver Roles in mCRC Care
EP: 10.mCRC Treatment Access: IRA Cost Cap Impact and Final Insights
Video content above is prompted by the following:
- To set the stage, what are some of the psychological and emotional aspects of treatment decision-making with patients entering the third-line stage of metastatic colorectal cancer?
- What are your recommendations for involving support services (such as social work or palliative care) to help patients navigate the psychosocial components of metastatic colorectal cancer (mCRC), and at what point in a patient’s care journey does this begin?
- What is the role of the caregiver in advanced mCRC in supporting a patient through these psychosocial components?
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening
November 20th 2024This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.
Read More
Why Right Heart Catheterization Confirming PAH Diagnosis May Be Underperformed
November 20th 2024Professional guidelines say that when pulmonary arterial hypertension (PAH) is diagnosed, right heart catheterization should be performed, but a quarter of the time, it isn’t—so investigators set out to discover why.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
New PsA Data Highlight Long-Term Benefits of Bimekizumab
November 19th 2024A trio of abstracts presented at ACR Convergence 2024, the annual meeting of the American College of Rheumatology, bear out the benefits of bimekizumab (Bimzelx; UCB Pharma) for use against active psoriatic arthritis (PsA).
Read More
